MoS2 flakes stabilized with DNA/RNA nucleotides: In vitro cell response

dc.contributor.authorCicuéndez Maroto, Mónica
dc.contributor.authorSilva, Virgília
dc.contributor.authorSantos, Joana
dc.contributor.authorCoimbra, Andreia
dc.contributor.authorOliveira, Helena
dc.contributor.authorAyán-Varela, Miguel
dc.contributor.authorParedes, Juan Ignacio
dc.contributor.authorVillar-Rodil, Silvia
dc.contributor.authorVila Gonzalo, María
dc.date.accessioned2024-01-30T10:55:07Z
dc.date.available2024-01-30T10:55:07Z
dc.date.issued2019
dc.description.abstractTwo-dimensional transition metal dichalcogenides (TMDCs), such as MoS2 and WS2, have recently emerged as nanomaterials with potential use in biomedicine. An attractive means to favor their interaction with biological media is the use of proper biomolecules as exfoliating/dispersing agents. Here, MoS2 flakes were stabilized with different small functional biomolecules such as adenosine monophosphate (AMP), guanosine monophosphate (GMP) and flavin mononucleotide (FMN) through the strong nucleotide-MoS2 interaction of Lewis acid-base type, rather than just on the weak dispersive and hydrophobic forces commonly associated with the use of many surfactants. The impact of the nucleotide-stabilized MoS2 flakes on the viability and cell proliferation, on the production of intracellular reactive oxygen species (ROS), and on the preosteoblast differentiation process (early stage) has been also evaluated, as well as the incorporation and intracellular localization of the nanomaterials by MC3T3-E1 and Saos-2 cells. The nucleotide-stabilized MoS2 flakes were found to exhibit excellent biocompatibility. Furthermore, their incorporation did not affect the integrity of the cell plasma membrane, which makes them ideal candidates for delivering drug/gene directly into cells. The in vitro cell response of tumor cells to these nanomaterials differs from that of undifferentiated cells, which provides the basis for their potential use in cancer therapy.
dc.description.departmentDepto. de Química en Ciencias Farmacéuticas
dc.description.facultyFac. de Farmacia
dc.description.refereedTRUE
dc.description.sponsorshipMinisterio de Economía y Competitividad (España)
dc.description.sponsorshipEuropean Commission
dc.description.sponsorshipPrincipado de Asturias
dc.description.statuspub
dc.identifier.citationCicuéndez M, Silva VS, Santos J, Coimbra A, Oliveira H, Ayán-Varela M, Paredes JI, Villar-Rodil S, Vila M. MoS2 flakes stabilized with DNA/RNA nucleotides: In vitro cell response. Mater Sci Eng C Mater Biol Appl. 2019 Jul;100:11-22. doi: 10.1016/j.msec.2019.02.002. Epub 2019 Feb 7. PMID: 30948045
dc.identifier.doi10.1016/J.MSEC.2019.02.002
dc.identifier.issn0928-4931
dc.identifier.officialurlhttps://doi.org/10.1016/j.msec.2019.02.002
dc.identifier.pimcd30948045
dc.identifier.urihttps://hdl.handle.net/20.500.14352/96400
dc.journal.titleMaterials Science and Engineering C
dc.language.isoeng
dc.page.final22
dc.page.initial11
dc.publisherElsevier
dc.relation.projectIDinfo:eu-repo/grantAgreement/SFRH/BPD/101468/2014
dc.relation.projectIDinfo:eu-repo/grantAgreement/MINECO/MAT2015-69844-R
dc.relation.projectIDinfo:eu-repo/grantAgreement/IDI/2018/000233
dc.rights.accessRightsrestricted access
dc.subject.ucmCiencias Biomédicas
dc.subject.unesco23 Química
dc.titleMoS2 flakes stabilized with DNA/RNA nucleotides: In vitro cell response
dc.typejournal article
dc.type.hasVersionVoR
dc.volume.number100
dspace.entity.typePublication
relation.isAuthorOfPublication94b23d40-3b2e-4dad-b72d-96c864251f14
relation.isAuthorOfPublication19f6e31c-3640-47ec-b9cc-b0aeb97ce502
relation.isAuthorOfPublication.latestForDiscovery94b23d40-3b2e-4dad-b72d-96c864251f14

Download

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
MoS2_flakes.pdf
Size:
2.4 MB
Format:
Adobe Portable Document Format

Collections